Literature DB >> 21119600

Human T-cell leukemia virus type 1 (HTLV-1) and leukemic transformation: viral infectivity, Tax, HBZ and therapy.

M Matsuoka1, K-T Jeang.   

Abstract

The human T-cell leukemia virus type 1 (HTLV-1) was the first retrovirus discovered to be causative of a human cancer, adult T-cell leukemia. The transforming entity of HTLV-1 has been attributed to the virally-encoded oncoprotein, Tax. Unlike the v-onc proteins encoded by other oncogenic animal retroviruses that transform cells, Tax does not originate from a c-onc counterpart. In this article, we review progress in our understanding of HTLV-1 infectivity, cellular transformation, anti-sense transcription and therapy, 30 years after the original discovery of this virus.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21119600      PMCID： PMC3413891          DOI： 10.1038/onc.2010.537

Source DB:  PubMed          Journal:  Oncogene        ISSN： 0950-9232            Impact factor:   9.867


  164 in total

1.  Human T-cell leukemia virus type 1 Tax attenuates gamma-irradiation-induced apoptosis through physical interaction with Chk2.

Authors:  H U Park; S-J Jeong; J-H Jeong; J H Chung; J N Brady
Journal:  Oncogene       Date:  2006-01-19       Impact factor: 9.867

2.  The role of NF-{kappa}B-1 and NF-{kappa}B-2-mediated resistance to apoptosis in lymphomas.

Authors:  Leon Bernal-Mizrachi; Christine M Lovly; Lee Ratner
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-02       Impact factor: 11.205

3.  The N-terminus of rodent and human MAD1 confers species-specific stringency to spindle assembly checkpoint.

Authors:  K Haller; K V Kibler; T Kasai; Y-H Chi; J-M Peloponese; V S R K Yedavalli; K-T Jeang
Journal:  Oncogene       Date:  2006-04-06       Impact factor: 9.867

4.  HTLV-1 propels untransformed CD4 lymphocytes into the cell cycle while protecting CD8 cells from death.

Authors:  David Sibon; Anne-Sophie Gabet; Marc Zandecki; Christiane Pinatel; Julien Thête; Marie-Hélène Delfau-Larue; Samira Rabaaoui; Antoine Gessain; Olivier Gout; Steven Jacobson; Franck Mortreux; Eric Wattel
Journal:  J Clin Invest       Date:  2006-04       Impact factor: 14.808

Review 5.  Modulation of nuclear factor-kappaB by human T cell leukemia virus type 1 Tax protein: implications for oncogenesis and inflammation.

Authors:  Jean-Marie Peloponese; Man Lung Yeung; Kuan-Teh Jeang
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

6.  Role for Akt/protein kinase B and activator protein-1 in cellular proliferation induced by the human T-cell leukemia virus type 1 tax oncoprotein.

Authors:  Jean-Marie Peloponese; Kuan-Teh Jeang
Journal:  J Biol Chem       Date:  2006-01-25       Impact factor: 5.157

Review 7.  Functional inactivation of p53 by human T-cell leukemia virus type 1 Tax protein: mechanisms and clinical implications.

Authors:  Yulia Tabakin-Fix; Inbal Azran; Yana Schavinky-Khrapunsky; Oren Levy; Mordechai Aboud
Journal:  Carcinogenesis       Date:  2005-11-23       Impact factor: 4.944

8.  Human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 use different receptor complexes to enter T cells.

Authors:  Kathryn S Jones; Kazunori Fugo; Cari Petrow-Sadowski; Ying Huang; Daniel C Bertolette; Ivonne Lisinski; Samuel W Cushman; Steven Jacobson; Francis W Ruscetti
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

9.  Thymus-derived leukemia-lymphoma in mice transgenic for the Tax gene of human T-lymphotropic virus type I.

Authors:  Hideki Hasegawa; Hirofumi Sawa; Martha J Lewis; Yasuko Orba; Noreen Sheehy; Yoshie Yamamoto; Takeshi Ichinohe; Yasuko Tsunetsugu-Yokota; Harutaka Katano; Hidehiro Takahashi; Junichiro Matsuda; Tetsutaro Sata; Takeshi Kurata; Kazuo Nagashima; William W Hall
Journal:  Nat Med       Date:  2006-03-19       Impact factor: 53.440

10.  HTLV-I antisense transcripts initiating in the 3'LTR are alternatively spliced and polyadenylated.

Authors:  Marie-Hélène Cavanagh; Sébastien Landry; Brigitte Audet; Charlotte Arpin-André; Patrick Hivin; Marie-Eve Paré; Julien Thête; Eric Wattel; Susan J Marriott; Jean-Michel Mesnard; Benoit Barbeau
Journal:  Retrovirology       Date:  2006-03-02       Impact factor: 4.602
View more
  118 in total

1.  Human T-cell leukemia virus type 1 (HTLV-1) latency: death signaling awakens the sleeping retrovirus.

Authors:  Kuan-Teh Jeang
Journal:  Cell Cycle       Date:  2011-11-15       Impact factor: 4.534

Review 2.  How virus persistence can initiate the tumorigenesis process.

Authors:  Simone Avanzi; Gualtiero Alvisi; Alessandro Ripalti
Journal:  World J Virol       Date:  2013-05-12

3.  Small noncoding RNAs in cells transformed by human T-cell leukemia virus type 1: a role for a tRNA fragment as a primer for reverse transcriptase.

Authors:  Katia Ruggero; Alessandro Guffanti; Alberto Corradin; Varun Kumar Sharma; Gianluca De Bellis; Giorgio Corti; Angela Grassi; Paola Zanovello; Vincenzo Bronte; Vincenzo Ciminale; Donna M D'Agostino
Journal:  J Virol       Date:  2014-01-08       Impact factor: 5.103

4.  RNA stability regulates human T cell leukemia virus type 1 gene expression in chronically-infected CD4 T cells.

Authors:  Hsin-Ching Lin; Peter J Simon; Riza M Ysla; Steven L Zeichner; Gary Brewer; Arnold B Rabson
Journal:  Virology       Date:  2017-05-04       Impact factor: 3.616

5.  Structural basis for cooperative regulation of KIX-mediated transcription pathways by the HTLV-1 HBZ activation domain.

Authors:  Ke Yang; Robyn L Stanfield; Maria A Martinez-Yamout; H Jane Dyson; Ian A Wilson; Peter E Wright
Journal:  Proc Natl Acad Sci U S A       Date:  2018-09-19       Impact factor: 11.205

6.  SIRT1 Suppresses Human T-Cell Leukemia Virus Type 1 Transcription.

Authors:  Hei-Man Vincent Tang; Wei-Wei Gao; Chi-Ping Chan; Yun Cheng; Jian-Jun Deng; Kit-San Yuen; Hidekatsu Iha; Dong-Yan Jin
Journal:  J Virol       Date:  2015-06-10       Impact factor: 5.103

7.  Human T cell leukemia virus type 2 (HTLV-2) Tax2 has a dominant activity over HTLV-1 Tax1 to immortalize human CD4+ T cells.

Authors:  Michitaka Imai; Masaya Higuchi; Hiroki Kawamura; Manami Yoshita; Masahiko Takahashi; Masayasu Oie; Hideaki Matsuki; Yuetsu Tanaka; Yutaka Aoyagi; Masahiro Fujii
Journal:  Virus Genes       Date:  2012-09-29       Impact factor: 2.332

8.  Human T-cell leukemia virus type 2 antisense viral protein 2 is dispensable for in vitro immortalization but functions to repress early virus replication in vivo.

Authors:  Han Yin; Priya Kannian; Nathan Dissinger; Robyn Haines; Stefan Niewiesk; Patrick L Green
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

9.  Radiation therapy for the management of patients with HTLV-1-associated adult T-cell leukemia/lymphoma.

Authors:  Charles B Simone; John C Morris; Donn M Stewart; Nicole E Urquhart; John E Janik; Robert J Kreitman; Elena Lita; Kevin Conlon; Gilian Wharfe; Thomas A Waldmann; Aradhana Kaushal
Journal:  Blood       Date:  2012-06-22       Impact factor: 22.113

10.  Human T-lymphotropic virus type 1-infected cells secrete exosomes that contain Tax protein.

Authors:  Elizabeth Jaworski; Aarthi Narayanan; Rachel Van Duyne; Shabana Shabbeer-Meyering; Sergey Iordanskiy; Mohammed Saifuddin; Ravi Das; Philippe V Afonso; Gavin C Sampey; Myung Chung; Anastas Popratiloff; Bindesh Shrestha; Mohit Sehgal; Pooja Jain; Akos Vertes; Renaud Mahieux; Fatah Kashanchi
Journal:  J Biol Chem       Date:  2014-06-17       Impact factor: 5.157
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.